Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas J Short

Showing results (51-60 of 346) with videos related to

Pageof 35
Sort By:
Journal of Hematology & Oncology|June 7, 2020
Evolving therapy of adult acute lymphoblastic leukemia: state-of-the-art treatment and future directionsBachar Samra, Elias Jabbour, Farhad Ravandi, et al.
Clinical Advances in Hematology & Oncology : H&O|May 10, 2018
Philadelphia chromosome-positive acute lymphoblastic leukemia in adults: current treatments and future perspectivesMusa Yilmaz, Hagop Kantarjian, Farhad Ravandi-Kashani, et al.
Journal of Hematology & Oncology|September 4, 2021
Prognostic and therapeutic implications of measurable residual disease in acute myeloid leukemiaMarisa J L Aitken, Farhad Ravandi, Keyur P Patel, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 2, 2018
SOHO State of the Art Update and Next Questions: Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaNicholas J Short, Hagop Kantarjian, Ching-Hon Pui, et al.
Leukemia & Lymphoma|November 29, 2024
Blinatumomab for the treatment of acute lymphoblastic leukemia in a real-world setting: clinical vignettesShilpa Paul, Elias Jabbour, E Dan Nichols, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 7, 2024
SOHO State of the Art Updates and Next Questions: Update on the Approach to Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaFadi G Haddad, Elias Jabbour, Nicholas J Short, et al.
Current Oncology Reports|June 14, 2021
Current Approaches to Philadelphia Chromosome-Positive B-Cell Lineage Acute Lymphoblastic Leukemia: Role of Tyrosine Kinase Inhibitor and Stem Cell TransplantKunhwa Kim, Elias Jabbour, Nicholas J Short, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 27, 2021
Optimizing Risk Stratification in Acute Myeloid Leukemia: Dynamic Models for a Dynamic Therapeutic LandscapeNicholas J Short, Martin S Tallman, Daniel A Pollyea, et al.
Current Oncology Reports|August 1, 2025
Current Treatment Strategies for FLT3-Mutated Acute Myeloid Leukemia in Patients not Candidates for Intensive ChemotherapyAlex Bataller, Nicholas J Short, Naval Daver, et al.
Therapeutic Advances in Hematology|June 18, 2019
Novel monoclonal antibody-based treatment strategies in adults with acute lymphoblastic leukemiaVeronica A Guerra, Elias J Jabbour, Farhad Ravandi, et al.
Pageof 35

Showing results (51-60 of 346) with videos related to

Sort By:
Pageof 35
Journal of Hematology & Oncology|June 7, 2020
Evolving therapy of adult acute lymphoblastic leukemia: state-of-the-art treatment and future directionsBachar Samra, Elias Jabbour, Farhad Ravandi, et al.
Clinical Advances in Hematology & Oncology : H&O|May 10, 2018
Philadelphia chromosome-positive acute lymphoblastic leukemia in adults: current treatments and future perspectivesMusa Yilmaz, Hagop Kantarjian, Farhad Ravandi-Kashani, et al.
Journal of Hematology & Oncology|September 4, 2021
Prognostic and therapeutic implications of measurable residual disease in acute myeloid leukemiaMarisa J L Aitken, Farhad Ravandi, Keyur P Patel, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 2, 2018
SOHO State of the Art Update and Next Questions: Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaNicholas J Short, Hagop Kantarjian, Ching-Hon Pui, et al.
Leukemia & Lymphoma|November 29, 2024
Blinatumomab for the treatment of acute lymphoblastic leukemia in a real-world setting: clinical vignettesShilpa Paul, Elias Jabbour, E Dan Nichols, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 7, 2024
SOHO State of the Art Updates and Next Questions: Update on the Approach to Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaFadi G Haddad, Elias Jabbour, Nicholas J Short, et al.
Current Oncology Reports|June 14, 2021
Current Approaches to Philadelphia Chromosome-Positive B-Cell Lineage Acute Lymphoblastic Leukemia: Role of Tyrosine Kinase Inhibitor and Stem Cell TransplantKunhwa Kim, Elias Jabbour, Nicholas J Short, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 27, 2021
Optimizing Risk Stratification in Acute Myeloid Leukemia: Dynamic Models for a Dynamic Therapeutic LandscapeNicholas J Short, Martin S Tallman, Daniel A Pollyea, et al.
Current Oncology Reports|August 1, 2025
Current Treatment Strategies for FLT3-Mutated Acute Myeloid Leukemia in Patients not Candidates for Intensive ChemotherapyAlex Bataller, Nicholas J Short, Naval Daver, et al.
Therapeutic Advances in Hematology|June 18, 2019
Novel monoclonal antibody-based treatment strategies in adults with acute lymphoblastic leukemiaVeronica A Guerra, Elias J Jabbour, Farhad Ravandi, et al.
Pageof 35